You are here: All Products  > Lynk Closes $16 Million C2 Round to Advance JAK Inhibitors for Autoimmune Diseases

Lynk Closes $16 Million C2 Round to Advance JAK Inhibitors for Autoimmune Diseases

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products